{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:50:27Z","timestamp":1777593027546,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.trsl.2011.06.003","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T11:48:22Z","timestamp":1309175302000},"page":"225-234","source":"Crossref","is-referenced-by-count":44,"title":["Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia"],"prefix":"10.1016","volume":"158","author":[{"given":"Charles J.","family":"Glueck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaaista","family":"Budhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lotner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Abuchaibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Nayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2011.06.003_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003086-199701000-00007","article-title":"Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis","volume":"334","author":"Glueck","year":"1997","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.blo.0000157539.67567.03","article-title":"Enoxaparin prevents progression of stages I and II osteonecrosis of the hip","volume":"435","author":"Glueck","year":"2005","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib3","first-page":"783","article-title":"Procoagulants and osteonecrosis","volume":"30","author":"Jones","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2011.06.003_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1055\/s-0037-1613138","article-title":"Leiden and prothrombin gene mutations in femoral head osteonecrosis","volume":"87","author":"Zalavras","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00402-004-0760-8","article-title":"Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee","volume":"125","author":"Bjorkman","year":"2005","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.trsl.2011.06.003_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003086-200408000-00023","article-title":"Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults","volume":"425","author":"Bjorkman","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib7","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2106\/00004623-200412000-00009","article-title":"Legg-Calve-Perthes disease and thrombophilia","volume":"86A","author":"Balasa","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.trsl.2011.06.003_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11999-008-0147-1","article-title":"Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population","volume":"466","author":"Chang","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0022-2143(97)90132-3","article-title":"Heterozygosity for the Leiden mutation of the factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens","volume":"130","author":"Glueck","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2011.06.003_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00003086-199909000-00017","article-title":"The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis","volume":"366","author":"Glueck","year":"1999","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","volume":"386","author":"Glueck","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s11999-008-0148-0","article-title":"Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head","volume":"466","author":"Glueck","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.trsl.2011.06.003_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1076029606298735","article-title":"Amaurosis fugax caused by heritable thrombophilia-hypofibrinolysis in cases without carotid atherosclerosis: thromboprophylaxis prevents subsequent transient monocular partial blindness","volume":"13","author":"Glueck","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MBC.0b013e3283436401","article-title":"Some considerations about the hypercoagulable states and their treatments","volume":"22","author":"Cacciapuoti","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.trsl.2011.06.003_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12185-009-0447-6","article-title":"Risk factors for thrombophilia in young adults presenting with thrombosis","volume":"90","author":"Yokus","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trsl.2011.06.003_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MBC.0b013e32832d6ce7","article-title":"Risk factors for clinical manifestations in carriers of factor V Leiden and prothrombin gene mutations","volume":"21","author":"DeSancho","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.trsl.2011.06.003_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1212\/01.WNL.0000149639.25136.CA","article-title":"The role of aromatization in testosterone supplementation: effects on cognition in older men","volume":"64","author":"Cherrier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2011.06.003_bib18","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.2009.639","article-title":"Circulating estradiol and mortality in men with systolic chronic heart failure","volume":"301","author":"Jankowska","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2011.06.003_bib19","doi-asserted-by":"crossref","first-page":"E631","DOI":"10.1152\/ajpendo.00467.2005","article-title":"Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization","volume":"291","author":"Spratt","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/713604678","article-title":"Estradiol in elderly men","volume":"5","author":"Vermeulen","year":"2002","journal-title":"Aging Male"},{"key":"10.1016\/j.trsl.2011.06.003_bib21","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.85.12.4500","article-title":"Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men","volume":"85","author":"Swerdloff","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/01.wnl.0000254473.88647.ca","article-title":"Serum estradiol and risk of stroke in elderly men","volume":"68","author":"Abbott","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2011.06.003_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.ju.0000165567.99142.1f","article-title":"Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism","volume":"174","author":"Ockrim","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.trsl.2011.06.003_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/pros.2990140410","article-title":"Estrogen therapy and liver function\u2014metabolic effects of oral and parenteral administration","volume":"14","author":"von Schoultz","year":"1989","journal-title":"Prostate"},{"key":"10.1016\/j.trsl.2011.06.003_bib26","first-page":"103","article-title":"Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients","volume":"55","author":"Hedlund","year":"1980","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.trsl.2011.06.003_bib27","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people","volume":"88","author":"Toorians","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib28","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2011.06.003_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hoibraaten","year":"2001","journal-title":"Br J Haematol"},{"issue":"Suppl. 2","key":"10.1016\/j.trsl.2011.06.003_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13697130701598548","article-title":"Effects of hormone treatment on hemostasis variables","volume":"10","author":"Kluft","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.trsl.2011.06.003_bib31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral\u00a0and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2011.06.003_bib32","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<2024::AID-CNCR25>3.0.CO;2-V","article-title":"Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden","volume":"79","author":"Weitz","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2011.06.003_bib33","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/djq211","article-title":"Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer","volume":"102","author":"Garber","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.trsl.2011.06.003_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-006-9212-1","article-title":"Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: case report and review of the literature","volume":"99","author":"Lycette","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.trsl.2011.06.003_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2106\/00004623-199906000-00006","article-title":"Osteonecrosis of the femoral head associated with pregnancy. A preliminary report","volume":"81","author":"Montella","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.trsl.2011.06.003_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3928\/01477447-20080201-36","article-title":"Bilateral osteonecrosis of the femoral head associated with pregnancy: four new cases and a review of the literature","volume":"31","author":"Ugwonali","year":"2008","journal-title":"Orthopedics"},{"key":"10.1016\/j.trsl.2011.06.003_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0037-1614564","article-title":"The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults","volume":"81","author":"Balasa","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0037-1615698","article-title":"Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke","volume":"85","author":"Glueck","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.lab.2003.10.015","article-title":"Nonarteritic anterior ischemic optic neuropathy: associations with homozygosity for the C677T methylenetetrahydrofolate reductase mutation","volume":"143","author":"Glueck","year":"2004","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2011.06.003_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/107602960401000404","article-title":"Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin","volume":"10","author":"Glueck","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/107602960501100301","article-title":"Amaurosis fugax: associations with heritable thrombophilia","volume":"11","author":"Glueck","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/107602960501100404","article-title":"Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion","volume":"11","author":"Glueck","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib43","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.metabol.2005.04.024","article-title":"The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage","volume":"54","author":"Glueck","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2011.06.003_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lab.2004.09.011","article-title":"Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia","volume":"145","author":"Glueck","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2011.06.003_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0026-0495(93)90042-M","article-title":"Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer","volume":"42","author":"Glueck","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2011.06.003_bib46","unstructured":"Roche Diagnostics GmbH. Testosterone II, Estradiol II: electrochemiluminescence immunoassay, Reference #s 05200067 160, 03000079 122. 2010:1-5."},{"key":"10.1016\/j.trsl.2011.06.003_bib47","first-page":"1","article-title":"Testosterone, Free, Serum (Equilibrium Ultrafiltration)","year":"2011","journal-title":"LabCorp Manual"},{"key":"10.1016\/j.trsl.2011.06.003_bib48","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/clinchem\/28.11.2286","article-title":"An improved ultrafiltration method for determining free testosterone in serum","volume":"28","author":"Vlahos","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2011.06.003_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.67B1.3155745","article-title":"Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment","volume":"67","author":"Ficat","year":"1985","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.trsl.2011.06.003_bib50","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2106\/JBJS.G.00616","article-title":"Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis","volume":"90","author":"Glueck","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.trsl.2011.06.003_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2011.06.003_bib52","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib53","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1210\/jc.2010-0102","article-title":"The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men","volume":"95","author":"Lakshman","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.trsl.2011.06.003_bib55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF03041030","article-title":"The risk of recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism","volume":"115","author":"Kyrle","year":"2003","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.trsl.2011.06.003_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/1076029610378499","article-title":"Hyperhomocysteinemia prevalence among patients with venous thromboembolism","author":"Kokturk","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2011.06.003_bib57","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1210\/jc.2003-031287","article-title":"Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2011.06.003_bib58","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.277.16.1305","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2011.06.003_bib59","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0002-9378(97)70615-X","article-title":"The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis","volume":"176","author":"Dizon-Townson","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.trsl.2011.06.003_bib60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J","article-title":"Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations","volume":"73","author":"Gregg","year":"1997","journal-title":"Am J\u00a0Med Genet"},{"key":"10.1016\/j.trsl.2011.06.003_bib61","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2174\/092986708784638852","article-title":"Carriership of factor V Leiden and evolutionary selection advantage","volume":"15","author":"Lindqvist","year":"2008","journal-title":"Curr Med Chem"},{"issue":"Suppl 2","key":"10.1016\/j.trsl.2011.06.003_bib62","first-page":"1","article-title":"Genetic heterogeneity in hereditary thrombophilia","volume":"30","author":"Reitsma","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.trsl.2011.06.003_bib63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejim.2007.03.016","article-title":"Pulmonary embolism associated with the use of anabolic steroids","volume":"19","author":"Liljeqvist","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.trsl.2011.06.003_bib64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1843.2006.00786.x","article-title":"High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism","volume":"11","author":"Erkekol","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.trsl.2011.06.003_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MBC.0b013e328331e664","article-title":"Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension","volume":"21","author":"Wong","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.trsl.2011.06.003_bib66","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/1076029607304726","article-title":"Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions","volume":"14","author":"Glueck","year":"2008","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524411001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524411001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T21:15:38Z","timestamp":1592687738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524411001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1931524411001915"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2011.06.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}